-
Citron's Andrew Left: Valeant Was Able To 'Game The System,' Now It's 'A Sinking Ship'
Wednesday, July 13, 2016 - 2:03pm | 408Read More...Andrew Left and his research firm, Citron Research, are known for short selling overvalued or over-hyped companies. Left led the bearish case against Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and even referred to the company as the "Enron" of the pharmaceutical industry back in...
